ArticleNeoplasia (New York, N.Y.)2023

Comprehensive profiling of EGFR mutation subtypes reveals genomic-clinical associations in non-small-cell lung cancer patients on first-generation EGFR inhibitors.

Yongkang Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.